NYX Nyse Euronext

NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for May 20121. Trading volumes in May reflected continuing improvement both year-over-year and month-over-month with heightened volatility in the global markets. U.S. equity options increased 4.7% and European cash increased 2.1% year-over-year. U.S. cash, European derivatives and U.S. equity options all registered month-over-month gains, reflecting increasing momentum quarter-to-date.

Highlights

• NYSE Euronext global derivatives ADV in May 2012 of 9.3 million contracts decreased 11.9% compared to May 2011, but increased 12.9% from April 2012 levels. Quarter-to-date, global derivatives ADV was 16.6% above first quarter 2012 levels.
• NYSE Euronext European derivatives products ADV in May 2012 of 5.0 million contracts decreased 22.1% compared to May 2011, but increased 17.6% from April 2012. Quarter-to-date, European derivatives products ADV was 40.5% above first quarter 2012 levels. Excluding Bclear, NYSE Liffe's trade administration and clearing service for OTC products, European derivatives products ADV decreased 9.0% compared to May 2011, but increased 8.2% from April 2012 levels. Quarter-to-date, on the same basis, European derivatives products ADV was 9.9% above first quarter 2012 levels.
• NYSE Euronext U.S. equity options ADV of 4.2 million contracts in May 2012 increased 4.7% compared to May 2011 levels and increased 7.7% from April 2012. Quarter-to-date, U.S. equity options ADV was 1.6% below first quarter 2012 levels. NYSE Euronext’s U.S. options exchanges accounted for 26.7% of total U.S. consolidated equity options trading in May 2012, up from 25.1% in May 2011 and up from 26.4% in April 2012. For the second consecutive month, NYSE Euronext was the #1 U.S. equity options exchange operator in May 2012 and NYSE Amex Options recorded record monthly market share of 16.1%.
• NYSE Liffe U.S. ADV of approximately 68,300 contracts decreased from 91,000 contracts in May 2011, but increased from 61,500 contracts in April 2012. Quarter-to-date, NYSE Liffe U.S. ADV was 32.5% below first quarter 2012 levels.
• NYSE Euronext European cash products ADV of 1.6 million transactions in May 2012 increased 2.1% compared to May 2011, but decreased 13.6% from April 2012 levels. Quarter-to-date, European cash products ADV was 9.2% above first quarter 2012 levels.
• NYSE Euronext U.S. cash products handled ADV of 1.9 billion shares in May 2012 decreased 9.3% compared to May 2011, but increased 9.7% compared to April 2012. Quarter-to-date, U.S. cash products ADV was 1.6% above first quarter 2012 levels. NYSE Euronext’s Tape A matched market share in May 2012 was 31.9%, down from 35.5% in May 2011 and up from 31.3% in April 2012.

Derivatives Trading

European Derivatives

• NYSE Euronext European derivatives products ADV in May 2012 of 5.0 million contracts decreased 22.1% compared to May 2011, but increased 17.6% from April 2012 levels. Quarter-to-date, European derivatives products ADV was 40.5% above first quarter 2012 levels.
• The 5.0 million in European derivatives futures and options contracts ADV in May 2012 consisted of 3.0 million contracts executed through our full-service LIFFE CONNECT trading platform and 2.0 million contracts, or 39.7%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products. Excluding Bclear, NYSE Liffe's trade administration and clearing service for OTC products, European derivatives products ADV decreased 9.0% compared to May 2011, but increased 8.2% compared to April 2012. Quarter-to-date, on the same basis, European derivatives products ADV was 9.9% above first quarter 2012 levels.
• Year-to-date, European derivatives products ADV of 3.9 million contracts was 23.2% below prior year levels. The 3.9 million in futures and options contracts ADV year-to-date consisted of 2.8 million contracts executed through LIFFE CONNECT trading platform and 1.1 million contracts, or 28.5%, executed through Bclear.
• Total fixed income products ADV of 2.1 million contracts in May 2012 decreased 8.8% from May 2011, but increased 17.9% from April 2012. Quarter-to-date, total fixed income products was 10.9% above first quarter 2012 levels. Year-to-date, total fixed income products ADV of 1.9 million contracts was 25.4% below prior year levels.
• Total equity products (including Bclear) ADV of 2.8 million contracts in May 2012 decreased 30.0% compared to May 2011, but increased 18.3% from April 2012. Quarter-to-date, total equity products ADV was 78.6% above first quarter 2012 levels. The 2.8 million contracts in equity products ADV in May 2012 consisted of 2.3 million contracts in individual equity products ADV and 0.5 million contracts in equity index products ADV. The 2.3 million contracts in individual equity products ADV consisted of 1.9 million in futures contracts, which represented a 36.2% decrease compared to May 2011 and 0.4 million in options contracts, which represented a 30.9% decrease compared to May 2011. The average net rate per contract for individual equity futures contracts is significantly lower than other European derivatives products. Year-to-date, total equity products ADV of 1.9 million contracts was 21.6% below prior year levels.
• Total commodities products ADV of approximately 73,000 contracts in May 2012 decreased 10.0% compared to May 2011 and decreased 9.6% compared to April 2012. Quarter-to-date, total commodities products ADV was 5.8% below first quarter 2012 levels. Year-to-date, total commodities product ADV of 80,000 contracts was 6.0% below prior year levels.

U.S. Derivatives

• NYSE Euronext U.S. equity options ADV of 4.2 million contracts in May 2012 increased 4.7% compared to May 2011 and increased 7.7% compared to April 2012. Quarter-to-date, U.S. equity options ADV was 1.6% below first quarter 2012 levels. Year-to-date, U.S. equity options ADV of 4.1 million contracts was 3.7% below prior year levels.
• Total U.S. consolidated equity options ADV decreased 1.7% to 15.7 million contracts in May 2012 compared to May 2011, but increased 6.5% compared to April 2012. Year-to-date, U.S. consolidated equity options ADV of 15.6 million contracts was 6.5% below prior year levels.
• NYSE Euronext’s U.S. options exchanges accounted for 26.7% of total U.S. consolidated equity options trading in May 2012, up from 25.1% in May 2011 and up from 26.4% in April 2012. For the second consecutive month, NYSE Euronext was the #1 U.S. equity options exchange operator in May 2012 and NYSE Amex Options recorded record monthly market share of 16.1%.
• NYSE Liffe U.S. ADV of approximately 68,300 contracts decreased from 91,000 contracts in May 2011, but increased from 61,500 contracts in April 2012. Quarter-to-date, NYSE Liffe U.S. ADV was 32.5% below first quarter 2012 levels. Year-to-date, U.S. futures and futures options ADV of 83,500 contracts was 71.0% above prior year levels.

Cash Trading

European Cash

• NYSE Euronext European cash products ADV of 1.6 million transactions in May 2012 increased 2.1% compared to May 2011, but decreased 13.6% compared to April 2012. Quarter-to-date, European cash products ADV was 9.2% above first quarter 2012 levels.
• Year-to-date, European cash products ADV of 1.6 million transactions was 3.8% below prior year levels.

U.S. Cash

• NYSE Euronext U.S. cash products handled ADV in May 2012 decreased 9.3% to 1.9 billion shares compared to May 2011, but increased 9.7% from April 2012. Quarter-to-date, U.S. cash products ADV was 1.6% above first quarter 2012 levels.
• Year-to-date, U.S. cash products handled ADV was 1.8 billion shares, down 18.5% from prior year levels.
• NYSE Euronext’s Tape A matched market share in May 2012 was 31.9%, down from 35.5% in May 2011, but up from 31.3% in April 2012.

Exchange Traded Funds

• NYSE Euronext U.S. matched exchange-traded funds ADV (included in volumes for Tape B and Tape C) of 251 million shares in May 2012 decreased 14.9% compared to May 2011, but increased 16.2% compared to April 2012. Quarter-to-date, U.S. matched exchange-traded funds ADV was 6.0% above first quarter 2012 levels.
• Year-to-date, NYSE Euronext U.S. matched exchange-traded funds ADV of 227 million shares was 18.3% below prior year levels.

Please click here for the Monthly Transaction Activity Data Table.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets – the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca – represent one-third of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the Fortune 500. For more information, please visit: http://www.nyx.com.

Disclaimer and Cautionary Note Regarding Forward-Looking Statements

This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext's plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext's results to differ materially from current expectations include, but are not limited to: NYSE Euronext's ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext's 2011 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorité des Marchés Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.

1 All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. NYSE Euronext European equities transactions count each buy and sell order as separate transactions, NYSE Euronext U.S. equities transactions count buy and sell orders together as a single transaction.

NYSE Euronext

Monthly Volume Summary

                          Average Daily Volume Total Volume Average Daily Volume Total Volume (Unaudited; contracts in thousands) May-12 May-11 % Chg May-12 May-11 % Chg YTD 2012

% Chg vs.YTD 2011

YTD 2012

% Chg vs.YTD 2011

  Number of Trading Days - European Cash 22 22 22 22 - 106 106 Number of Trading Days - European Derivatives 23 22 23 22 107 107 Number of Trading Days - U.S. Markets 22 21 22 21 104 104   European Derivatives Products 5,022 6,448 -22.1 % 115,511 141,867 -18.6 % 3,862 -23.2 % 413,233 -21.8 % of which Bclear 1,995 3,121 -36.1 % 45,883 68,668 -33.2 % 1,099 -24.6 % 117,558 -23.2 %   Total Fixed Income Products 2,113 2,318 -8.8 % 48,609 50,989 -4.7 % 1,850 -25.4 % 197,986 -24.0 %   Short Term Interest Rate Products 1,930 2,150 -10.2 % 44,393 47,291 -6.1 % 1,696 -27.7 % 181,467 -26.3 % Medium and Long Term Interest Rate Products 1 183 168 9.0 % 4,216 3,699 14.0 % 154 13.7 % 16,519 15.8 %   Total Equity Products 2 2,836 4,049 -30.0 % 65,218 89,087 -26.8 % 1,932 -21.6 % 206,730 -20.1 %   Individual Equity Products 2,300 3,559 -35.4 % 52,890 78,293 -32.4 % 1,441 -25.1 % 154,217 -23.7 % Futures 1,910 2,995 -36.2 % 43,935 65,901 -33.3 % 956 -26.2 % 102,282 -24.8 % Options 389 563 -30.9 % 8,954 12,392 -27.7 % 485 -22.9 % 51,935 -21.4 % Equity Index Products 536 491 9.2 % 12,328 10,794 14.2 % 491 -9.0 % 52,513 -7.3 %   of which Bclear 1,995 3,121 -36.1 % 45,883 68,668 -33.2 % 1,099 -24.6 % 117,558 -23.2 % Individual Equity Products 1,922 3,074 -37.5 % 44,217 67,634 -34.6 % 1,028 -25.9 % 109,980 -24.5 % Futures 1,858 2,973 -37.5 % 42,737 65,414 -34.7 % 927 -27.4 % 99,213 -26.1 % Options 64 101 -36.2 % 1,480 2,220 -33.3 % 101 -8.4 % 10,767 -6.6 % Equity Index Products 72 47 54.2 % 1,667 1,034 61.2 % 71 2.0 % 7,578 3.9 %   Commodity Products 73 81 -10.0 % 1,684 1,790 -5.9 % 80 -6.0 % 8,517 -4.2 %   U.S. Derivatives Products   Equity Options 3   NYSE Euronext Options Contracts 4,204 4,015 4.7 % 92,480 84,319 9.7 % 4,101 -3.7 % 426,453 -2.7 % Total Consolidated Options Contracts 15,734 16,008 -1.7 % 346,148 336,177 3.0 % 15,635 -6.5 % 1,626,089 -5.6 %   NYSE Group Share of Total 26.7 % 25.1 % 26.7 % 25.1 % 26.2 % 0.8 % 26.2 % 0.8 %   NYSE Liffe U.S.   Futures and Futures Options Volume* 68.3 91.0 -24.9 % 1,571 2,001 -21.5 % 83.5 71.0 % 9,022.7 74.2 %   European Cash Products (trades in thousands) 1,612 1,579 2.1 % 35,455 34,743 2.1 % 1,640 -3.8 % 173,826 -2.9 %   Equities 1,560 1,520 2.6 % 34,317 33,447 2.6 % 1,586 -3.2 % 168,141 -2.3 % Exchange-Traded Funds 14 16 -14.3 % 302 353 -14.3 % 15 -22.3 % 1,545 -21.6 % Structured Products 33 38 -12.2 % 733 835 -12.2 % 34 -18.5 % 3,626 -17.7 % Bonds 5 5 -5.0 % 103 108 -5.0 % 5 -9.0 % 514 -8.1 %   U.S. Cash Products (shares in millions) 5 1,890 2,084 -9.3 % 41,583 43,754 -5.0 % 1,793 -18.5 % 186,520 -17.7 %   NYSE Listed (Tape A) Issues 4   Handled Volume 5 1,334 1,445 -7.6 % 29,357 30,336 -3.2 % 1,280 -18.6 % 133,140 -17.8 % Matched Volume 6 1,266 1,367 -7.4 % 27,861 28,704 -2.9 % 1,210 -18.6 % 125,801 -17.8 % Total NYSE Listed Consolidated Volume 3,971 3,851 3.1 % 87,362 80,867 8.0 % 3,904 -9.4 % 406,029 -8.5 %   Share of Total Consolidated Volume Handled Volume 5 33.6 % 37.5 % -3.9 % 33.6 % 37.5 % -3.9 % 32.8 % -3.7 % 32.8 % -3.7 % Matched Volume 6 31.9 % 35.5 % -3.6 % 31.9 % 35.5 % -3.6 % 31.0 % -3.5 % 31.0 % -3.5 %  

NYSE Arca, MKT and Regional (Tape B) Listed Issues

  Handled Volume 5 291 352 -17.2 % 6,406 7,382 -13.2 % 268 -20.6 % 27,914 -19.8 % Matched Volume 6 262 317 -17.4 % 5,755 6,650 -13.5 % 240 -20.8 % 24,954 -20.1 %

Total NYSE Arca & MKT Listed Consolidated Volume

1,248 1,352 -7.7 % 27,460 28,402 -3.3 % 1,144 -12.9 % 118,959 -12.0 %   Share of Total Consolidated Volume Handled Volume 5 23.3 % 26.0 % -2.7 % 23.3 % 26.0 % -2.7 % 23.5 % -2.2 % 23.5 % -2.2 % Matched Volume 6 21.0 % 23.4 % -2.4 % 21.0 % 23.4 % -2.4 % 21.0 % -2.1 % 21.0 % -2.1 %   Nasdaq Listed (Tape C) Issues   Handled Volume 5 265 287 -8.0 % 5,820 6,036 -3.6 % 245 -15.5 % 25,466 -14.7 % Matched Volume 6 228 244 -6.6 % 5,010 5,120 -2.2 % 208 -15.6 % 21,617 -14.8 % Total Nasdaq Listed Consolidated Volume 1,904 2,034 -6.4 % 41,886 42,720 -2.0 % 1,801 -11.0 % 187,290 -10.1 %   Share of Total Consolidated Volume Handled Volume 5 13.9 % 14.1 % -0.2 % 13.9 % 14.1 % -0.2 % 13.6 % -0.7 % 13.6 % -0.7 % Matched Volume 6 12.0 % 12.0 % 0.0 % 12.0 % 12.0 % 0.0 % 11.5 % -0.7 % 11.5 % -0.7 %   Exchange-Traded Funds 5,7   Handled Volume 5 280 328 -14.7 % 6,163 6,896 -10.6 % 254 -17.9 % 26,415 -17.1 % Matched Volume 6 251 295 -14.9 % 5,528 6,204 -10.9 % 227 -18.3 % 23,574 -17.5 % Total ETF Consolidated Volume 1,237 1,282 -3.5 % 27,216 26,925 1.1 % 1,114 -8.4 % 115,900 -7.5 %   Share of Total Consolidated Volume Handled Volume 5 22.6 % 25.6 % -3.0 % 22.6 % 25.6 % -3.0 % 22.8 % -2.6 % 22.8 % -2.6 % Matched Volume 6 20.3 % 23.0 % -2.7 % 20.3 % 23.0 % -2.7 % 20.3 % -2.5 % 20.3 % -2.5 %      

1

Data includes currency products.

2

Includes all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives.

3

Includes trading in U.S. equity options contracts, not equity-index options.

4

Includes all volume executed in NYSE Group crossing sessions.

5

Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots.

6

Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges.

7

Data included in previously identified categories.

*

ADVs calculated with the appropriate number of NYSE Liffe U.S. trading days. Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities. All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.